Literature DB >> 27041741

Scrambler Therapy for the management of chronic pain.

Neil Majithia1, Thomas J Smith2, Patrick J Coyne3, Salahadin Abdi4, Deirdre R Pachman5, Daniel Lachance6, Randy Shelerud7, Andrea Cheville7, Jeffrey R Basford7, David Farley8, Carrie O'Neill5, Kathryn J Ruddy5, Frank Sparadeo9, Andreas Beutler5, Charles L Loprinzi10.   

Abstract

PURPOSE: Chronic pain is a widespread and debilitating condition, encountered by physicians in a variety of practice settings. Although many pharmacologic and behavioral strategies exist for the management of this condition, treatment is often unsatisfactory. Scrambler Therapy is a novel, non-invasive pain modifying technique that utilizes trans-cutaneous electrical stimulation of pain fibers with the intent of re-organizing maladaptive signaling pathways. This review was conducted to further evaluate what is known regarding the mechanisms and mechanics of Scrambler Therapy and to investigate the preliminary data pertaining to the efficacy of this treatment modality.
METHODS: The PubMed/Medline, SCOPUS, EMBASE, and Google Scholar databases were searched for all articles published on Scrambler Therapy prior to November 2015. All case studies and clinical trials were evaluated and reported in a descriptive manner.
RESULTS: To date, 20 reports, of varying scientific quality, have been published regarding this device; all but one small study, published only as an abstract, provided results that appear positive.
CONCLUSION: The positive findings from preliminary studies with Scrambler Therapy support that this device provides benefit for patients with refractory pain syndromes. Larger, randomized studies are required to further evaluate the efficacy of this approach.

Entities:  

Keywords:  Chemotherapy-induced peripheral neuropathy; Chronic pain; Pain; Scrambler Therapy

Mesh:

Year:  2016        PMID: 27041741      PMCID: PMC4973603          DOI: 10.1007/s00520-016-3177-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  27 in total

1.  Treatment of Postherpetic Pain With Scrambler Therapy, a Patient-Specific Neurocutaneous Electrical Stimulation Device.

Authors:  Thomas J Smith; Giuseppe Marineo
Journal:  Am J Hosp Palliat Care       Date:  2013-07-08       Impact factor: 2.500

2.  Chronic pain treatment and scrambler therapy: a multicenter retrospective analysis.

Authors:  Christian Compagnone; Fernanda Tagliaferri
Journal:  Acta Biomed       Date:  2015-09-14

3.  Decreased low back pain intensity and differential gene expression following Calmare®: results from a double-blinded randomized sham-controlled study.

Authors:  Angela R Starkweather; Patrick Coyne; Debra E Lyon; R K Elswick; Kyungeh An; Jamie Sturgill
Journal:  Res Nurs Health       Date:  2015-01-08       Impact factor: 2.228

4.  Managing chronic pain: results from an open-label study using MC5-A Calmare® device.

Authors:  Marianna Ricci; Sara Pirotti; Emanuela Scarpi; Marco Burgio; Marco Maltoni; Elisabetta Sansoni; Dino Amadori
Journal:  Support Care Cancer       Date:  2011-03-11       Impact factor: 3.603

5.  An exploratory study on the effectiveness of "Calmare therapy" in patients with cancer-related neuropathic pain: A pilot study.

Authors:  Sang Chul Lee; Keun Suk Park; Jee Youn Moon; Eun Jung Kim; Yong-Chul Kim; Hyejin Seo; Joon Kyung Sung; Da Jeong Lee
Journal:  Eur J Oncol Nurs       Date:  2015-12-29       Impact factor: 2.398

6.  Clinical experiences on the effect of scrambler therapy for patients with postherpetic neuralgia.

Authors:  Young Kwon Ko; Ho Young Lee; Wang Yong Lee
Journal:  Korean J Pain       Date:  2013-01-04

7.  Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy.

Authors: 
Journal:  Pain Suppl       Date:  1986

8.  Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy.

Authors:  Deirdre R Pachman; Breanna L Weisbrod; Drew K Seisler; Debra L Barton; Kelliann C Fee-Schroeder; Thomas J Smith; Daniel H Lachance; Heshan Liu; Randy A Shelerud; Andrea L Cheville; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2014-09-24       Impact factor: 3.603

Review 9.  Transcutaneous electrical nerve stimulation (TENS) for chronic pain.

Authors:  Kelechi E Nnoaham; Jharna Kumbang
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

10.  The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee.

Authors:  Timothy R Deer; Nagy Mekhail; David Provenzano; Jason Pope; Elliot Krames; Michael Leong; Robert M Levy; David Abejon; Eric Buchser; Allen Burton; Asokumar Buvanendran; Kenneth Candido; David Caraway; Michael Cousins; Michael DeJongste; Sudhir Diwan; Sam Eldabe; Kliment Gatzinsky; Robert D Foreman; Salim Hayek; Philip Kim; Thomas Kinfe; David Kloth; Krishna Kumar; Syed Rizvi; Shivanand P Lad; Liong Liem; Bengt Linderoth; Sean Mackey; Gladstone McDowell; Porter McRoberts; Lawrence Poree; Joshua Prager; Lou Raso; Richard Rauck; Marc Russo; Brian Simpson; Konstantin Slavin; Peter Staats; Michael Stanton-Hicks; Paul Verrills; Joshua Wellington; Kayode Williams; Richard North
Journal:  Neuromodulation       Date:  2014-08
View more
  24 in total

Review 1.  TFOS DEWS II pain and sensation report.

Authors:  Carlos Belmonte; Jason J Nichols; Stephanie M Cox; James A Brock; Carolyn G Begley; David A Bereiter; Darlene A Dartt; Anat Galor; Pedram Hamrah; Jason J Ivanusic; Deborah S Jacobs; Nancy A McNamara; Mark I Rosenblatt; Fiona Stapleton; James S Wolffsohn
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

Review 2.  Future cancer research priorities in the USA: a Lancet Oncology Commission.

Authors:  Elizabeth M Jaffee; Chi Van Dang; David B Agus; Brian M Alexander; Kenneth C Anderson; Alan Ashworth; Anna D Barker; Roshan Bastani; Sangeeta Bhatia; Jeffrey A Bluestone; Otis Brawley; Atul J Butte; Daniel G Coit; Nancy E Davidson; Mark Davis; Ronald A DePinho; Robert B Diasio; Giulio Draetta; A Lindsay Frazier; Andrew Futreal; Sam S Gambhir; Patricia A Ganz; Levi Garraway; Stanton Gerson; Sumit Gupta; James Heath; Ruth I Hoffman; Cliff Hudis; Chanita Hughes-Halbert; Ramy Ibrahim; Hossein Jadvar; Brian Kavanagh; Rick Kittles; Quynh-Thu Le; Scott M Lippman; David Mankoff; Elaine R Mardis; Deborah K Mayer; Kelly McMasters; Neal J Meropol; Beverly Mitchell; Peter Naredi; Dean Ornish; Timothy M Pawlik; Jeffrey Peppercorn; Martin G Pomper; Derek Raghavan; Christine Ritchie; Sally W Schwarz; Richard Sullivan; Richard Wahl; Jedd D Wolchok; Sandra L Wong; Alfred Yung
Journal:  Lancet Oncol       Date:  2017-10-31       Impact factor: 41.316

3.  Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial.

Authors:  Charles Loprinzi; Jennifer G Le-Rademacher; Neil Majithia; Ryan P McMurray; Carrie R O'Neill; Markus A Bendel; Andreas Beutler; Daniel H Lachance; Andrea Cheville; David M Strick; David F Black; Jon C Tilburt; Thomas J Smith
Journal:  Support Care Cancer       Date:  2019-06-17       Impact factor: 3.603

4.  Chemotherapy-Induced Peripheral Neuropathy: A Challenge for Clinicians.

Authors:  Salahadin Abdi; Patrick M Dougherty
Journal:  Oncology (Williston Park)       Date:  2016-11-15       Impact factor: 2.990

Review 5.  Chemotherapy-induced peripheral neuropathy: A current review.

Authors:  Nathan P Staff; Anna Grisold; Wolfgang Grisold; Anthony J Windebank
Journal:  Ann Neurol       Date:  2017-06-05       Impact factor: 10.422

6.  Polyester Nanoparticle Encapsulation Mitigates Paclitaxel-Induced Peripheral Neuropathy.

Authors:  R Ganugula; M Deng; M Arora; H-L Pan; M N V Ravi Kumar
Journal:  ACS Chem Neurosci       Date:  2019-01-17       Impact factor: 4.418

7.  Scrambler therapy improves pain in neuromyelitis optica: A randomized controlled trial.

Authors:  Maureen A Mealy; Sharon L Kozachik; Lawrence J Cook; Lauren Totonis; Ruth Andrea Salazar; Jerilyn K Allen; Marie T Nolan; Thomas J Smith; Michael Levy
Journal:  Neurology       Date:  2020-04-08       Impact factor: 9.910

8.  Differential response to scrambler therapy by neuropathic pain phenotypes.

Authors:  Young Gi Min; Hyun Seok Baek; Kyoung-Min Lee; Yoon-Ho Hong
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

9.  Complementary Therapies for Symptom Management in Cancer Patients.

Authors:  Aanchal Satija; Sushma Bhatnagar
Journal:  Indian J Palliat Care       Date:  2017 Oct-Dec

Review 10.  Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: State of art and an innovative approach for prevention.

Authors:  Ester Oneda; Chiara Abeni; Laura Zanotti; Elisabetta Zaina; Sara Bighè; Alberto Zaniboni
Journal:  World J Clin Oncol       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.